What is Baxter International's kidney care — net sales?

Baxter International (BAX) reported kidney care — net sales of $1.12B in Q2 2024.

How has Baxter International's kidney care — net sales changed year-over-year?

Baxter International's kidney care — net sales increased by 0.2% year-over-year, from $1.12B to $1.12B.

What does kidney care — net sales mean?

Total revenue earned from the Kidney Care business segment after accounting for returns and discounts.

How do you interpret kidney care — net sales?

Growth indicates strong market demand and successful commercial execution within the renal care sector.

How does kidney care — net sales compare across companies?

Standard revenue metric; peers in the medical device space report this to show segment-specific market share trends.

Baxter International BAX Kidney Care — Net Sales

Discontinued — last reported Q2 '24

Other segment segments

Medical Products & Therapies

$1.29B+1.8%

Healthcare Systems & Technologies

$705M+0.1%

Pharmaceuticals

$621M+6.9%

Similar metrics at other companies

DVAUS Dialysis And Related Lab Services — Health Care Organization Revenue

$2.52B+11.5%

DVAU S Dialysis — Total revenues

$2.81B+2.9%

DVAU.S. dialysis — Total revenue net of intersegment revenue

$2.83B+4.3%

DVAOther Operating Segments with Intersegment — Dialysis patient service revenues

$357.84M+20.3%

DVAOther - Ancillary Services — Dialysis patient service revenues

$248.18M+18.3%

DVAU.S.Dialysis And Related Lab Services — Revenue

$2.92B+3.9%

Other financials

Income statement

See full

Revenue$2.7B+2.9%

Gross profit$891.0M+3.5%

Operating income$66.0M+13.8%

Net income-$15.0M-112%

EPS (diluted)-$0.03-112%

Balance sheet

See full

Cash & equivalents$2.0B-12.1%

Total debt$224.0M-8.9%

Total equity$6.0B-14.7%

Total assets$19.8B-6.8%

Cash flow

See full

Operating cash flow$213.0M+210%

CapEx$128.3M+15.0%

Free cash flow$83.0M-42.1%

Valuation

See full

Market cap$10.27B-50.6%

Enterprise value$8.48B-55.6%

P/S0.9×-1.0×

Profitability

See full

Gross margin30.1%-5.9pp

Operating margin-2.7%—

Net margin-9.7%+62.5pp

FCF margin3%-2.4pp

Returns & leverage

See full

Return on equity-16.7%-76.7pp

Debt / equity0×0.0×

Current ratio1.9×-0.2×

Where this comes from

Reported directly by Baxter International in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Baxter International’s 10-Q, filed August 6, 2024, on SEC EDGAR. View the filing →

Ask your AI about Baxter International's kidney care — net sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Baxter International's kidney care — net sales?: Baxter International (BAX) reported kidney care — net sales of $1.12B in Q2 2024.
How has Baxter International's kidney care — net sales changed year-over-year?: Baxter International's kidney care — net sales increased by 0.2% year-over-year, from $1.12B to $1.12B.
What does kidney care — net sales mean?: Total revenue earned from the Kidney Care business segment after accounting for returns and discounts.
How do you interpret kidney care — net sales?: Growth indicates strong market demand and successful commercial execution within the renal care sector.
How does kidney care — net sales compare across companies?: Standard revenue metric; peers in the medical device space report this to show segment-specific market share trends.